External validation of radiobiological models for local control prediction in lung cancer patients treated with stereotactic body radiation therapy
Authors:
Open Access
- 10 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1431140
Abstract
Background: The debate regarding the accuracy of radiobiological models for local control (LC) prediction in lung cancer patients undergoing stereotactic body radiation therapy (SBRT) remains unresolved. The study seeks to externally validate the predictive efficacy of radiobiological models using single-institutional SBRT database.Methods: The cohort comprised 153 patients diagnosed with primary or metastatic lung cancer who underwent SBRT. The study employed three radiobiological models to estimate the probability of 2-year LC, including the Liu model, Klement model, and Ohri model. Furthermore, the likelihood of 3-year LC was predicted using the Liu model, Klement model, Gucken model, and Santiago model. The performance of the prediction models was assessed through the AUC values of the receiver operating characteristic (ROC) curve and the calibration plots.Results: Local recurrence was observed in 38.6% of patients (59/153) within two years, and in 43.1% (66/153) within three years after the radiotherapy. The ROC curves indicated discriminative power for all the 2-year and 3-year models, with the exception of the Klement model. The Ohri model showed a significantly improved discriminative ability than the Klement model for 2-year prediction, while it was not statistically significant when compared to the Liu model. However, no significant differences were found among the four models in terms of 3-year LC prediction. The calibration plots, using the Hosmer-Lemeshow goodness-of-fit test, confirmed that the predicted probabilities of the models were in agreement with the actual observation with P>0.05, except for the 2-year LC prediction using the Klement model.Conclusion: Considering the balance between prediction accuracy and model simplicity, it is recommended to utilize the Ohri model for 2-year LC prediction and either the Gucken model or Santiago model for 3-year LC prediction.Keywords
This publication has 32 references indexed in Scilit:
- A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff pointClinical and Translational Radiation Oncology, 2021
- Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual TreatmentsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysisEuropean Journal of Radiology, 2020
- Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non–small-cell Lung CancerClinical Lung Cancer, 2018
- Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Modeling Local Control After Hypofractionated Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Report From the Elekta Collaborative Lung Research GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Stereotactic body radiotherapy using a radiobiology‐based regimen for stage I nonsmall cell lung cancerCancer, 2011